Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $278.32 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Heron Therapeutics, Inc. | $103.93 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $91.56 | 1 | $0 (2019) |
| Chiesi USA, Inc. | $22.85 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $18.11 | 1 | $0 (2017) |
| Mindray DS USA, Inc. | $14.28 | 1 | $0 (2021) |
| Amgen Inc. | $14.09 | 1 | $0 (2017) |
| Novo Nordisk Inc | $13.50 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $103.93 | 1 | Heron Therapeutics, Inc. ($103.93) |
| 2021 | $14.28 | 1 | Mindray DS USA, Inc. ($14.28) |
| 2019 | $114.41 | 2 | Merck Sharp & Dohme Corporation ($91.56) |
| 2017 | $45.70 | 3 | Novartis Pharmaceuticals Corporation ($18.11) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/10/2023 | Heron Therapeutics, Inc. | APONVIE (Drug) | Food and Beverage | Cash or cash equivalent | $103.93 | General |
| Category: NAUSEAVOMITING | ||||||
| 01/13/2021 | Mindray DS USA, Inc. | A SERIES (Device) | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: Anesthesia Equipment | ||||||
| 08/19/2019 | Merck Sharp & Dohme Corporation | BRIDION (Drug) | Food and Beverage | In-kind items and services | $91.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2019 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $22.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/04/2017 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: DERMATOLOGY | ||||||
| 06/12/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.50 | General |
| 01/09/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Endocrinology | ||||||
About Dr. Samir Abdo, M.D
Dr. Samir Abdo, M.D is a Surgery healthcare provider based in Eldorado, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1578612982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samir Abdo, M.D has received a total of $278.32 in payments from pharmaceutical and medical device companies, with $103.93 received in 2023. These payments were reported across 7 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($278.32).
Practice Information
- Specialty Surgery
- Location Eldorado, IL
- Active Since 01/09/2007
- Last Updated 01/30/2015
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1578612982
Products in Payments
- APONVIE (Drug) $103.93
- BRIDION (Drug) $91.56
- CLEVIPREX (Drug) $22.85
- COSENTYX (Biological) $18.11
- A SERIES (Device) $14.28
- Prolia (Biological) $14.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.